Recilisib sodium
Product Specifications
CAS Number
922139-31-9
Target
Akt, Others, PI3K
Related Pathways
Cytoskeletal Signaling, PI3K/Akt/mTOR signaling, Others
Bioactivity
Recilisib, also known as ON 01210.Na, is a radioprotectant, which modifys cell cycle distribution patterns in cancer cells subjected to radiation therapy, and it has been identified as a potential candidate for radiation protection studies. It appears that Recilisib radioprotective mechanisms involve prevention of p53-dependent and independent radiation-induced apoptosis.
Smiles
[Na].OC(=O)c1ccc(\C=C\S(=O)(=O)Cc2ccc(Cl)cc2)cc1
Molecular Formula
C16H13ClNaO4S
Molecular Weight
359.78
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC403105-500 1x 500 µL
MUC4 (Mucin 4 / Gastric Mucin) (MUC4/3105), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details